The Trump Administration Seeks to Spur Domestic Drug Manufacturing with Regulatory Relief EO
By EsqSocial Corporation 08/05/25
On May 5, President Trump issued an Executive Order (EO) titled “Regulatory Relief to Promote Domestic Production of Critical Medicines,” with the stated purpose of eliminating “regulatory barriers to the domestic production of the medicines Americans need.” The EO establishes the policy that the regulation of manufacturing pharmaceutical products and inputs should be streamlined to......
By: Akin Gump Strauss Hauer & Feld LLP